| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC0586 | Amg-0347 | Novel transient receptor potential type V1 (TRPV1) receptor antagonist |
|
| DCC0587 | Amg-0696 | Novel disrupter of glucokinase-glucokinase regulatory protein (GK-GKRP) binding, inducing GK translocation from the nucleus to the cytoplasm in rats and blood glucose reduction in mice |
|
| DCC0588 | Amg-151 | Novel glucokinase activator, decreasing fasting and postprandial glycaemia |
|
| DCC0589 | Amg-18 Hydrochloride | Novel selective IRE1α inhibitor |
|
| DCC0590 | Amg21629 | Potent and selective TRPV1 antagonist |
|
| DCC0591 | Amg222 | Novel potent DPP-IV inhibitor |
|
| DCC0592 | Amg-25 | Novel potent and selective inhibitor of c-Kit |
|
| DCC0593 | Sotorasib racemate Featured | Sotorasib racemate (Compound A) is an orally active racemate of Sotorasib, a covalent inhibitor of KRAS G12C mutant which induces adaptive feedback activation of MAPK pathway. Sotorasib racemate also exerts inhibitor activity against KRAS G12C induced cancer and can be applied to cancer research. |
|
| DCC0594 | Amg-7549 | Novel Disrupter of Glucokinase−Glucokinase Regulatory Protein (GK−GKRP) Binding |
|
| DCC0595 | Amg-7980 | Novel highly specific phosphodiesterase 10A (PDE10A) ligand with good uptake in the striatum |
|
| DCC0596 | Amg8163 | Vanilloid receptor TRPV1 antagonist |
|
| DCC0597 | amg8562 | Novel vanilloid receptor TRPV1 modulator |
|
| DCC0598 | Amg8563 | Novel vanilloid receptor TRPV1 modulator |
|
| DCC0599 | Amg9090 | Specific transient receptor potential ankyrin 1 (TRPA1) antagonist |
|
| DCC0600 | Ami-5 Trihydrate | Quantity (mg or Unit) Unit Price ($/mg or $/Unit) Final Price 100 $15.75 Total: $1,575.00 50 $18.20 Total: $910.00 25 $21.35 Total: $533.75 10 $25.20 Total: $252.00 5 $29.75 Total: $148.75 |
|
| DCC0601 | Amids-stilbene | Cysteine trapping agent, protecting cysteines exposed to the aqueous environment from subsequently added mal-PEG |
|
| DCC0602 | Amifostine Hydrate | Radiation-protective agent, causing splenic vasodilation and blocking autonomic ganglia |
|
| DCC0603 | Aminoprofen | NSAID (non-steroidal anti-inflammatory drug) and non selective COX inhibitor |
|
| DCC0604 | Amiselimod | Immunomodulator |
|
| DCC0605 | Amitriptyline Embonate | Inhibitor of the re-uptake of norepinephrine and serotonin, inhibiting N-methyl-D-aspartate (NMDA) receptors |
|
| DCC0606 | Amlodipine Mesylate | L-type calcium channel blocker |
|
| DCC0607 | Amoscanate | Anthelmintic agent against infections with the human hookworm |
|
| DCC0608 | Amotosalen Hydrochloride | Light-activated DNA, RNA crosslinking agent |
|
| DCC0609 | Amp-579 | Potent A1/A2A adenosine receptor agonist, protecting against myocardial infarction |
|
| DCC0610 | Ampa Stabilizer (r,r)-2a | The most potent AMPA stabilizer |
|
| DCC0611 | Amp-acrylate | Novel rapid and specific inhibitor of electrophile-sensitive DEAD-box proteins with high selectivity over the wild-type enzyme |
|
| DCC0612 | Ampk Activator C2 | Potent allosteric activator of AMPK |
|
| DCC0613 | Ampk Activator Vi | Potent allosteric activator of the AMPK |
|
| DCC0614 | ampk Agonist F17 | Novel agonist of AMPK signaling |
|
| DCC0615 | Amrc272 | Novel Metallo-β-lactamase Inhibitor |
|
